1. The effect of L-dopa and propranolol on human CSF cyclic nucleotides;Belmaker;Psychopharmacology (Berl.),1978
2. Pharmacologically induced changes in the 3′5′-cyclic guanosine monophosphate content of rat cerebellar cortex: difference between apomorphine, haloperidol and harmaline;Biggio;J. Pharmacol. Exp. Ther.,1977
3. Effects of dopaminergic agonists and antagonists on in vivo cyclic nucleotide content: relation of guanosine 3′5′ mono-phosphate (cGMP);Breese;Life Sci.,1978
4. Fahn, S., R.L. Elton, and members of the UPDRS Development Committee, 1987. Unified Parkinson's Disease Rating Scale. In: Fahn, S., Marsden, C.D., Goldstein, M., Calne, D.B. (Eds.), Recent Developments in Parkinson's Disease, vol II. MacMillan, Florham Park, New Jersey, pp. 153–163.
5. Modulation of in vivo striatal transmitter release by nitric oxide and cyclic GMP;Guevara-Guzmán;J. Neurochem.,1994